Washington University Pulmonary Vascular Symposium: Pulmonary Hypertension Conference & Venous Thromboembolic Conference

Washington University Pulmonary Vascular Symposium is planned interprofessionally by physicians, nurses, and pharmacists.  This two-day Symposium will include a one-day Pulmonary Hypertension Conference and a one-day Venous Thromboembolic Conference, attendees will be able to attend one or both days.  The goal of this activity is to enhance knowledge, skills, performance and care of patient with pulmonary vascular disease

Pulmonary Hypertension Conference – Friday, September 26, 2025
This Pulmonary Hypertension Conference is designed for pulmonologists, cardiologists, intensivists, rheumatologists, hematologists, hospitalists, radiologists, thoracic surgeons, nurses, pharmacists and allied health professionals.  This will be of interest to practitioners who evaluate and manage pulmonary hypertension patients.  This 6.75-hour live course will provide education through plenary lectures, breakout sessions, case presentations, panel discussions and question & answer sessions.  The activity will highlight best practices across the spectrum of pulmonary hypertension disorders. 

Venous Thromboembolic Conference – Saturday, September 27, 2025
Venous Thromboembolic Conference is designed for pulmonologists, critical care physicians, vascular surgeons, interventional radiologists, interventional cardiologists, hematologists, emergency room physicians, cardiac surgeons, hospitalists and primary care physicians, nurses and pharmacists. This may also be of interest to others who care for venous thromboembolic patients. This 6.5-hour live course will provide education through lectures, case presentations, panel discussions, question & answer sessions. The activity will highlight best practices across the spectrum of venous thromboembolic diseases and its long term sequalae.

1. Accurately diagnose pulmonary hypertension based on contemporary hemodynamic definitions and PH classifications.
2. Interpret the critical diagnostic studies which will lead to accurate diagnosis.
3. Identifying PH patients that would benefit from being treated by expert centers, while ensuring appropriate management of more commonly encountered Group 2 and 3 PH.
4. Apply contemporary risk assessment tools and treatment algorithm for Group 1 PH patients, including prostacyclin pathway activators and activin signal inhibitor.
5. Formulate a comprehensive treatment approach for patients with Heart failure with preserved ejection fraction and group 2 PH, including therapies to improve dysregulated metabolism.
6. Recognize when PH develops in the backdrop of ILDs and determine who are candidates for inhaled vasodilator therapy.
7. Diagnose chronic thromboembolic pulmonary disease after acute venothromboembolic disease and assess factors that differentiate between surgical and medical interventions.
8. Diagnose chronic thromboembolic pulmonary disease after acute venothromboembolic disease and assess factors that differentiate between surgical and medical interventions.
9. Analyze the latest evidence based guidelines for the diagnosis and management of pulmonary embolism, including risk stratification and therapeutic decision making.
10. Apply appropriate risk assessment tools to guide anticoagulation selection and determine the need for advanced interventions in patients with acute pulmonary embolism.
11. Develop an approach to implementing a multidisciplinary Pulmonary Embolism Response Team (PERT) model to optimize VTE management and patient outcomes.
12. Evaluate the role of various imaging modalities in the diagnosis and follow up of pulmonary embolism to ensure timely and accurate decision making.
13. Recommend appropriate long-term management strategies, including anticoagulation duration, risk factor modification, and follow-up planning for patients with acute and chronic VTE.
14. Implement structured protocols for screening, diagnosing, and managing highrisk VTE patients, integrating AIdriven tools where applicable to improve clinical outcomes and reduce complications.

Registration for the live in-person course

This is a continuing medical education activity intended for healthcare providers.

In order to assure you receive further information regarding this course/registration, please add ‘[email protected]’ to your email contact list. If you do not, please be sure to check your spam/junk folders for future correspondence.

*** IMPORTANT NOTE for Employees of industry (e.g., pharmaceutical & device companies): DO NOT REGISTER HERE. Please email [email protected] for pre-approval for attendance at this course. Should you register without pre-approval, your registration will be cancelled and refunded less a $25 administrative fee.

Registration

Registration will be available until September 25, 2025, 12:00pm CT.  After this time, please register on-site.

Fees includes enrollment, continuing education credits (ABIM MOC – see ABIM MOC Instructions), educational materials, continental breakfast, lunch and refreshment breaks (paid registrants only).

Registration/Payment Policy: Your full payment in advance completes your registration and ensures your enrollment in this course. 

Cancellations: Registration fee less $50 administrative charge is refundable if cancellation is received in writing by emailing [email protected] by September 17, 2025. Registration fees are not transferable.

Minimum and Maximum Enrollments Have Been Established.

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available for this Activity
American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 13.25 (6.75 Friday / 6.5 Saturday) AMA PRA Category 1 Credits™. Physicians should claim   the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 13.25 (6.75 Friday / 6.5 Saturday) ANCC contact hours.

 Accreditation Council for Pharmacy Education (ACPE)This activity is approved for a maximum of 13.25 (6.75 Friday / 6.5 Saturday) knowledge-based contact hours (1.325 (Friday 6.75 / 6.5 Saturday) CEUs) in states that recognize ACPE. Participants should only claim credit commensurate with the extent of their participation in the activity. Unique Universal Activity Number to be determined.  To be awarded credit, attendees must sign in, provide their NABP ePID number and date of birth.

American Board of Internal Medicine Maintenance of Certification (ABIM MOC)
Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.25 (6.75 Friday / 6.5 Saturday) MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Credit.

Interprofessional Continuing Education (IPCE)This activity was planned by and for the healthcare team, and learners will receive 13.25 (6.75 Friday / 6.5 Saturday) Interprofessional Continuing Education (IPCE) credits for learning and change.

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

Continuing Medical Education at Washington University School of Medicine fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations thereof. If any participant of this meeting is in need of accommodations, please do not hesitate to submit written requests, at least one month prior to seminar date.

Suggested Hotel Accommodations
Make your hotel reservations directly with the hotel.
Please note the last day to make reservations is at the discounted rate is Tuesday, August 26, 2025. 
Room Rate: $149(+tax) per night, based upon availability

DoubleTree by Hilton Hotel - Chesterfield
16625 Swingley Ridge Road, Chesterfield, MO 63017. 
(636) 532-5000
http://doubletreechesterfield.com

Via Link:  DoubleTree by Hillton Pulmonary Vascular Symposium - St. Louis Reservations

Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of non-refundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.

The Master Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

If you are a company and would like to exhibit or provide an educational grant for this educational program, please contact Stacy Partrich at [email protected]